Screener
Taysha Gene Therapies, Inc. TSHA Operating Lease Liabilities
Operating Lease Liabilities at other companies
Other financials
Where this comes from
Reported directly by Taysha Gene Therapies, Inc. in its filing.
Tagged under the XBRL concept us-gaap:OperatingLeaseLiabilityNoncurrent.
The source filing: Taysha Gene Therapies, Inc.’s 10-Q, filed May 6, 2026.
- Filed
- May 6, 2026, 8:30 AM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-207666
| Line item | March 31,2026 | December 31,2025 |
|---|---|---|
| Accrued expenses and other current liabilities | 15,534 | 20,277 |
| Total current liabilities | 20,098 | 26,552 |
| Term loan, net | 48,961 | 50,106 |
| Operating lease liability, net of current portion | 17,766 | 18,172 |
| Other non-current liabilities | 1,582 | 1,552 |
| Total liabilities | 88,407 | 96,382 |
| Commitments and contingencies - Note 13 | ||
| Stockholders' equity |
Item 1. Financial Statements.
FAQ
- What is Taysha Gene Therapies, Inc.'s operating lease liabilities?
- Taysha Gene Therapies, Inc. (TSHA) reported operating lease liabilities of $17.77M in Q1 2026.
- How has Taysha Gene Therapies, Inc.'s operating lease liabilities changed year-over-year?
- Taysha Gene Therapies, Inc.'s operating lease liabilities increased by 3.9% year-over-year, from $17.09M to $17.77M.
- What is the long-term trend for Taysha Gene Therapies, Inc.'s operating lease liabilities?
- Over 3 years (2022 to 2025), Taysha Gene Therapies, Inc.'s operating lease liabilities has grown at a -3.8% compound annual growth rate (CAGR), from $20.44M to $18.17M.
- What does operating lease liabilities mean?
- Long-term portion of operating lease obligations extending beyond one year, representing committed future rent payments.
Ask your AI about Taysha Gene Therapies, Inc.'s operating lease liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude